US Broker Ratings

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 19% Upside with Strong Buy Ratings

For investors with an eye on the burgeoning field of oncology, BeOne Medicines Ltd. (ONC) presents a compelling opportunity. Operating out of Switzerland, this biotech heavyweight is making waves in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and Promising Genetic Medicine Pipeline

Krystal Biotech, Inc. (NASDAQ: KRYS) stands at the forefront of the biotechnology sector with its innovative approach to genetic medicine. Headquartered in Pittsburgh, Pennsylvania, the company is making significant strides..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 43.77% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is carving out a prominent niche in the biotechnology sector with its focus on innovative treatments for B-cell mediated diseases. As of today, the company’s..

West Pharmaceutical Services (WST) Stock Analysis: A 46% Upside Potential That Investors Can’t Ignore

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector, holds a prominent position in the medical instruments and supplies industry. With a market capitalization of $17.03..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 184% Potential Upside for Investors

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biopharmaceutical sector, holds significant promise for investors seeking opportunities in the rapidly evolving field of radiopharmaceuticals. With a strong focus..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Healthcare Giant with a 2.43% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a key player in the healthcare sector, stands at the intersection of innovation and tradition in the medical instruments and supplies industry. Known for..

IDEXX Laboratories, Inc. (IDXX): Investor Outlook with 10.40% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within diagnostics and research, is capturing attention with its robust market presence and growth potential. With a..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 56% Potential Upside with Strong Analyst Support

Doximity, Inc. (NYSE: DOCS) stands poised in the healthcare information services sector, presenting an intriguing investment opportunity, particularly for those eyeing substantial potential upside. With a market capitalization of $7.65..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, with a significant footprint in the medical distribution industry. As of its latest financial data, the..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 37.58% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, specifically within the medical device industry. With a market capitalization of $5.17 billion, this San Francisco-based company is..

Charles River Laboratories (CRL): Investor Outlook Amidst Volatility and Strategic Alliances

Charles River Laboratories International, Inc. (NYSE: CRL) commands attention in the healthcare sector, specifically within diagnostics and research. With a market cap of $10.81 billion, this Massachusetts-headquartered company has established..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring an 18.54% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $3.24..

Stryker Corporation (SYK) Stock Analysis: Exploring a 20% Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, specifically within the medical devices industry, commands a significant market presence. With a market capitalization of $135.78 billion, Stryker..

Corcept Therapeutics (CORT) Stock Analysis: 114% Potential Upside Beckons Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing the attention of the investment community with its remarkable potential upside and strategic focus on groundbreaking treatments for complex disorders. As a prominent..

ICON plc (ICLR) Stock Analysis: A Strategic Look at the Healthcare Leader with a 10.54% Upside Potential

ICON plc (NASDAQ: ICLR) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Dublin, Ireland, ICON specializes in providing comprehensive outsourced..

Legend Biotech Corporation (LEGN) Stock Analysis: A Biotech Powerhouse with a 248% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is a notable player in the biotechnology sector, specializing in the development of innovative cell therapies for multiple oncology indications. With its headquarters in Somerset,..

DexCom, Inc. (DXCM) Stock Analysis: Healthcare Giant with a 16.93% Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leading force in the medical devices sector, is drawing significant attention from investors due to its impressive growth prospects and innovative product line. With a..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 27.47% Potential Upside

argenx SE (NASDAQ: ARGX), a leader in the biotechnology sector, is captivating investor attention with its significant market presence and promising product pipeline. With a market capitalization of $50.42 billion,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 17% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, has been a solid name in the medical devices industry since its founding in 1952. Headquartered in Hercules,..

Molina Healthcare Inc (MOH) Stock Report: Analyzing the Healthcare Giant’s Growth Amidst a Potential -7.53% Downside

Molina Healthcare Inc (MOH), a prominent player in the U.S. healthcare plans sector, operates primarily within Medicaid and Medicare programs. Based in Long Beach, California, Molina has carved a niche..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds